New kidney injury warnings added to all GLP-1 drugs by FDA
The US Food and Drug Administration has instructed all GLP-1 drug-makers to update warning labels to include the risk of serious kidney injury that can result from dehydration. This comes after cases of acute kidney injury have required hemodialysis. Source of Article